Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two doses of filgrastim in treatment of neutropenia
IRCT20180103038196N8Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Feb 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of filgrastim in neutropenia (2 arms), sponsored by Golestan University of Medical Sciences. Started Feb 2019; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on IRCT20180103038196N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180103038196N8.